Internship

Software Technology Solutions Intern

Software Engineering, Healthsight

Posted on 3/31/2025

Becton Dickinson

Becton Dickinson

10,001+ employees

Develops and sells medical devices and diagnostics

Compensation Overview

$25 - $34/hr

No H1B Sponsorship

San Diego, CA, USA

Candidates must be authorized to work for ANY employer in the US. The job requires a minimum of 4 days of in-office presence per week for most roles, indicating a hybrid work model.

Category
Full-Stack Engineering
Software QA & Testing
Software Engineering
Required Skills
Python
Requirements
  • Currently pursuing a Bachelor of Science in Computer Science/Engineering
  • Ability to work in a team environment and develop enterprise level applications, under the direction of senior staff and management
  • Excellent written and verbal communication skills
Responsibilities
  • Become familiar with the automation initiatives and challenges and collaboratively identify project opportunities
  • Work on coding, testing, and debugging software applications
  • Participate in meetings, contribute to the development of features
  • Gain hands-on experience in all stages of the software development lifecycle
  • Collaborate with the quality engineering team to adopt test automation best practices
  • Design, build and maintain frontend or backend automation framework
  • Collect data from various sources, including databases, APIs, and web scraping tools
  • Communicate insights in a clear and concise manner with the manager along your progress
  • Design python tools and applications, develop your ability to write well-structured, production quality code, and be involved in implementing continuous integration
Desired Qualifications
  • Familiarity with Selenium, Playwright, C#, Python

BD (Becton, Dickinson and Company) focuses on improving health through medical technology. The company operates in three main areas: BD Medical, BD Life Sciences, and BD Interventional, each targeting different healthcare needs. BD develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products to hospitals, laboratories, and healthcare providers worldwide. Their products aim to enhance patient outcomes, reduce healthcare costs, and improve safety and efficiency in medical care. What sets BD apart from competitors is its comprehensive approach to healthcare solutions across various segments, allowing for a wide range of services and products that cater to diverse healthcare challenges. The company's goal is to advance healthcare by providing effective tools and technologies that support better medical discovery and care delivery.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eysins, Switzerland

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's $1.2B investment boosts syringe manufacturing and drug delivery capabilities.
  • AI integration in healthcare offers BD opportunities to enhance diagnostic accuracy and efficiency.
  • Growing demand for pre-fillable syringes aligns with BD's recent manufacturing investments.

What critics are saying

  • Increased competition in the syringe market may impact BD's market share.
  • Integration of Cubex LLC's assets may challenge BD's operational efficiency.
  • New executive appointments may lead to strategic shifts disrupting current operations.

What makes Becton Dickinson unique

  • BD's global reach spans North America, EMEA, Greater Asia, and Latin America.
  • BD's diverse segments include Medical, Life Sciences, and Interventional, covering various healthcare needs.
  • BD's focus on innovation enhances patient outcomes and operational efficiencies in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...

INACTIVE